Lawrence R. McGee

2.5k citations

28 papers · 1.3k indexed · h-index 19

Organic Chemistry top 2%
- Click Chemistry and Applications 3
- Asymmetric Synthesis and Catalysis 2
Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 2
Molecular Biology
- Chemical Synthesis and Analysis 4
- PI3K/AKT/mTOR signaling in cancer 2
Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 2
Cancer Research
Genetics
- Chronic Lymphocytic Leukemia Research 2
Infectious Diseases
- HIV/AIDS drug development and treatment 2

Co-authors: David A. Evans Javier Bartrolí James M. Takacs Michael D. Ennis David J. Mathre Timothy D. Cushing Daniela Metz Douglas A. Whittington
Cited by: Organic Chemistry Toxicology Molecular Biology
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of the American Chemical Society (4 papers)Tetrahedron Letters (3 papers)
Partner nations: United States

In The Last Decade

Lawrence R. McGee

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Lawrence R. McGee

Since Specialization

Citations

This map shows the geographic impact of Lawrence R. McGee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence R. McGee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence R. McGee more than expected).

Fields of papers citing papers by Lawrence R. McGee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence R. McGee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence R. McGee. The network helps show where Lawrence R. McGee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lawrence R. McGee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence R. McGee Line = papers co-authored together Lawrence R. McGee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel series of tunable µOR modulators with enhanced brain penetration for the treatment of opioid use disorder, pain and neuropsychiatric indications Bioorganic & Medicinal Chemistry Letters ·Alok Nerurkar,Thomas T. Nguyen,Meboobur Rahman,Ulhas Bhatt,Kevin Li,Yihong Li,Pingyu Ding,Frederick J. Seidl,R. Wilken,J. Jack Lee,Ramon Syahrial,Julia Andrés-Rodríguez,Jeff Johnson,David Sperandio,Lawrence R. McGee,Beth D. Youngblood,Neil Schwartz,Donald R. Gehlert,KIMBERLY L. DREWS	2023	1
2	Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101) Journal of Medicinal Chemistry ·Yosup Rew,Xiaohui Du,John Eksterowicz,Haiying Zhou,Nadine S. Jahchan,Liusheng Zhu,Xuelei Yan,Hiroyuki Kawai,Lawrence R. McGee,Julio C. Medina,Tom Huang,A. Hasart,Tatiana Zavorotinskaya,Sharmada Jois,Joanna Waszczuk,Erica L. Jackson,Elizabeth Huang,Qiuping Ye,Valeria R. Fantin,Daqing Sun	2018	21
3	Synthesis and SAR study of potent and selective PI3Kδ inhibitors Bioorganic & Medicinal Chemistry Letters ·Minna Bui,Xiaolin Hao,Youngsook Shin,Mario Cardozo,Xiaodong He,Kirk R. Henne,Julia Suchomel,John D. McCarter,Lawrence R. McGee,Tisha San Miguel,Julio C. Medina,Deanna Mohn,Thuy Tran,Sharon Wannberg,Jamie Wong,Simon Wong,Leeanne Zalameda,Daniela Metz,Timothy D. Cushing	2015	18
4	AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia Molecular Cancer Therapeutics ·Cong Li,Liqin Liu,Lingming Liang,Zhen Xia,Zhihong Li,Xianghong Wang,Lawrence R. McGee,カズオオオツカ,Angus M. Sinclair,Alexander Kamb,Dineli Wickramasinghe,Kang Dai	2014	27
5	Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction Bioorganic & Medicinal Chemistry Letters ·Yingcai Wang,Jieping Zhu,Jiwen Liu,Xiaoqi Chen,Jeff Mihalic,Victor Ronquillo,Ming Yu,Daqing Sun,Frank Kayser,Lawrence R. McGee,Mei-Chu Lo,Ada Chen,Jing Zhou,Qiuping Ye,Xin Huang,Alexander Long,P. Yakowec,Jonathan D. Oliner,Steven H. Olson,Julio C. Medina	2014	13
6	Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure–activity relationship, and co-crystal structures Bioorganic & Medicinal Chemistry Letters ·Kexue Li,Lawrence R. McGee,Jerome Workman,Athena Sudom,Jinsong Liu,Steven M. Rubenstein,Mohmed K. Anwer,Timothy D. Cushing,Youngsook Shin,P.J. Meulenhoff,Fei Lee,John Eksterowicz,Paul Faulder,Bohdan Waszkowycz,Olga Plotnikova,Ellyn Farrelly,Shou-Hua Xiao,Guoqing Chen,Zhulun Wang	2013	53
7	An Expeditious Synthesis of the MDM2–p53 Inhibitor AM-8553 Journal of the American Chemical Society ·Brian S. Lucas,Benjamin Fisher,Lawrence R. McGee,Steven H. Olson,Julio C. Medina,Eugene Cheung	2012	32
8	Imidazo-pyrazine derivatives as potent CXCR3 antagonists Bioorganic & Medicinal Chemistry Letters ·Xiaohui Du,Darin J. Gustin,Xiaoqi Chen,Jason Duquette,Lawrence R. McGee,Zhulun Wang,Karen Ebsworth,Kirk R. Henne,Bryan D. Lemon,Ji Ma,Shichang Miao,R. L. Batten,Timothy J. Sullivan,George Tonn,Tassie L. Collins,Julio C. Medina	2009	29
9	INT131: A Selective Modulator of PPARγ Journal of Molecular Biology ·Alykhan Motani,Zhulun Wang,Jennifer Weiszmann,Lawrence R. McGee,Gary Lee,Qingxiang Liu,Jocelyn Staunton,Zexu Fang,Fabiana Silva Fernandes,Michelle Lindström,Jinsong Liu,Antoinette Meyer,Juan C. Jaén,Nigel P.C. Walker,R. Marc Learned,Jinlong Chen,Yang Li	2009	98
10	Synthesis of novel biaryl 2-benzimidazoles and 2-benzothiazoles Tetrahedron Letters ·Kanaka Pattabiraman,Bénédicte Bouillot,V. Bruckner,Lawrence R. McGee,David Chow	2009	6
11	New Series of Potent, Orally Bioavailable, Non-Peptidic Cyclic Sulfones as HIV-1 Protease Inhibitors Journal of Medicinal Chemistry ·Choung U. Kim,Lawrence R. McGee,Steven H. Krawczyk,Pankaj jadhav,Yoko Harada,S. Swaminathan,Norbert Bischofberger,Ming S. Chen,Julie M. Cherrington,Shelly Xiong,Linda C. Griffin,Kenneth C. Cundy,Angela Lee,Betty Yu,Yongli Zhao,John W. Erickson	1996	56
12	Inhibition of HIV-1 RNase H Activity by Nucleotide Dimers and Monomers Antiviral chemistry & chemotherapy ·Abd Alwan Hussain Najm,S. H. KRAWCZYK,Lawrence R. McGee,N. Bischofberger,Andrew Mulato,Julie M. Cherrington	1996	8
13	From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold Journal of the American Chemical Society ·Robert S. McDowell,Brent Blackburn,Thomas R. Gadek,Lawrence R. McGee,Thomas E. Rawson,Mark E. Reynolds,Kirk Robarge,Todd C. Somers,Eugene D. Thorsett	1994	82
14	Lack of regio- and stereospecificity in oxidation of (+) camphor by Streptomyces griseus enriched in cytochrome P-450soy Biochemical and Biophysical Research Communications ·F. Sima Sariaslani,Lawrence R. McGee,Michael K. Trower,Fulton G. Kitson	1990	17
15	The photobiology of the gilvocarcins. Total synthesis of defucogilvocarcin V and a related photoactive vinyl phenol The Journal of Organic Chemistry ·Lawrence R. McGee,Pat N. Confalone	1988	22
16	Microbial transformation of precocene II: oxidative reactions by Streptomyces griseus Applied and Environmental Microbiology ·F. Sima Sariaslani,Lawrence R. McGee,Derick W. Ovenall	1987	26
17	Chiral enolate design Pure and Applied Chemistry ·David A. Evans,James M. Takacs,Lawrence R. McGee,Michael D. Ennis,David J. Mathre,Javier Bartrolí	1981	206
18	ChemInform Abstract: ENANTIOSELECTIVE ALDOL CONDENSATIONS. 3. ERYTHRO‐SELECTIVE CONDENSATIONS VIA ZIRCONIUM ENOLATES Chemischer Informationsdienst ·David A. Evans,Lawrence R. McGee	1981	11
19	Aldol diastereoselection zirconium enolates. Product-selective, enolate structure independent condensations. Tetrahedron Letters ·David A. Evans,Lawrence R. McGee	1980	106
20	Mass spectral data for gas chromatograph-mass spectral identification of some irregular monoterpenes Journal of Chemical & Engineering Data ·William W. Epstein,Lawrence R. McGee,C. Dale Poulter,証三今井	1976	20

About Lawrence R. McGee

Lawrence R. McGee is a scholar working on Toxicology, Organic Chemistry and Pharmacology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Asymmetric Synthesis and Catalysis (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Organic Chemistry (742 citations), Toxicology (31 citations) and Molecular Biology (613 citations). Lawrence R. McGee has collaborated with scholars based in United States. Frequent co-authors include David A. Evans, Javier Bartrolí, James M. Takacs, Michael D. Ennis, David J. Mathre, Timothy D. Cushing, Daniela Metz, Douglas A. Whittington, Pat N. Confalone and Yuk‐Ching Tse‐Dinh. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Tetrahedron Letters, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact